Calpha methylation in molecular recognition. Application to substance P and the two neurokinin-1 receptor binding sites.
Two binding sites NK-1M (major, more abundant) and NK-1m (minor) are associated with the neurokinin-1 receptor. For the first time with a bioactive peptide, the Calpha methylation constraint, shown to be a helix stabiliser in model peptides, was systematically used to probe the molecular requirements of NK-1M and NK-1m binding sites and the previously postulated bioactive helical conformation of substance P (SP). Seven Calpha methylated analogues of the undecapeptide SP (from position 5-11) have been assayed for their affinities and their potencies to stimulate second messenger production. The consequences of Calpha methylation on the structure of SP have been analysed by circular dichroism and nuclear magnetic resonance combined with restrained molecular dynamics. The decreased potencies of six out of these seven Calpha methylated SP analogues do not allow the identification of any clear-cut differences in the structural requirements between the two binding sites. Strikingly, the most active analogue, [alphaMeMet5]SP, leads to variable subnanomolar affinity and potency when interacting with the NK-1m binding site. The conformational analyses show that the structural consequences associated with Calpha methylation of SP are sequence dependent. Moreover, a single Calpha methylation is not sufficient by itself to drastically stabilize a helical structure even pre-existing in solution, except when Gly9 is substituted by an alpha-aminoisobutyric acid. Furthermore, Calpha methylation of residues 5 and 6 of SP in the middle of the postulated helix does not stabilize, but decreases (to different extents) the stability of the helical structure previously observed in the 4-8 domain of other potent SP analogues.
Sagan
S
S
Laboratoire de Chimie Organique Biologique and Laboratoire de Chimie Structurale Organique et Biologique, Université Pierre et Marie Curie, Paris, France. sagan@ccr.jussieu.fr
Lequin
O
O
Frank
F
F
Convert
O
O
Ayoub
M
M
Lavielle
S
S
Chassaing
G
G
D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D016466:CHO Cells; D002462:Cell Membrane; D002942:Circular Dichroism; D006224:Cricetinae; D000242:Cyclic AMP; D004305:Dose-Response Relationship, Drug; D007295:Inositol Phosphates / Q000737:chemistry; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D000432:Methanol / Q000494:pharmacology; D008745:Methylation; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism*; D011485:Protein Binding; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D018040:Receptors, Neurokinin-1 / Q000737:chemistry*; D013373:Substance P / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000378:metabolism
D007295:Inositol Phosphates; D008024:Ligands; D010455:Peptides; D018040:Receptors, Neurokinin-1; D013373:Substance P; D000242:Cyclic AMP; D000432:Methanol